AT THE 45th ANNUAL DIA CONFERENCE (SAN DIEGO, CA)-June 22, 2009: Aris Global, the leading provider of software solutions for the life sciences industry, today announced the introduction of agCapture, an integrated EDC solution that offers life science organizations a cost-effective alternative for capturing, managing and reporting clinical research data. Companies will now be able to conduct all data management activities electronically and seamlessly integrate with other systems and departments, such as safety and CTMS. The level of interoperability and integration that agCapture offers will appeal to organizations that want to eliminate duplicate data entry, and prevent delays and inefficiencies in adverse event reporting.
During the DIA 45th Annual Meeting, Aris Global will be demonstrating and presenting agCapture in its booth #521 at the San Diego Convention Center.
agCapture is an industry-proven EDC system, based on software developed by Aris Global and InferMed, a leading provider of advanced decision support and data-capture solutions for clinical research and practice. The solution seamlessly integrates with ARISg, the market-leading pharmacovigilance system from Aris Global, enabling companies to reduce the efforts required for SAE reconciliation and immediately take the necessary steps for case processing. agCapture provides interoperability with clinical systems such as central labs, ePRO, interactive voice response systems (IVRS), and clinical trial management systems, including Aris Global’s agClinical, to help easily manage complex trials from end to end. A number of intuitive, interactive tools for study definition, online and off-line remote data entry, and remote study monitoring simplify study setup and shorten the time to database closure. Service offerings include study setup, training, integration with third-party software, and 24x7x365 multi-language support for investigators.
“Aris Global effectively addresses the needs of life science organizations to keep their global trials on track, on budget, and on time,” said Simon Sparkes, vice president, corporate strategy and marketing, Aris Global. “With this offering, companies benefit from having a proven EDC solution that has been deployed worldwide in hundreds of sites and studies, is interoperable with third-party clinical and pharmacovigilance systems, and is backed by the stability, leadership and responsive support that Aris Global has been delivering for more than 20 years.”
Delivered as a hosted Software-as-a-Service offering, agCapture will also help reduce costs by eliminating the investment in new software, hardware, or new application and infrastructure support staff. The solution is offered at a pricing level that is specifically designed to accommodate a multitude of changes, making it affordable for companies looking to reduce costs and stay within set budgets.
About Aris Global
Aris Global is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. More than 300 life science organizations rely on the company’s advanced solutions for maintaining regulatory compliance, managing and mitigating risk, improving operational efficiency and easily sharing information on a global basis.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.